Cargando…
Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019)
The results of the international St. Gallen Consensus Conference for the treatment of patients with primary breast cancer were discussed this year by a working group of leading breast cancer experts in view of the therapy recommendations for everyday clinical practice in Germany. Three of the breast...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570611/ https://www.ncbi.nlm.nih.gov/pubmed/31217628 http://dx.doi.org/10.1055/a-0897-6457 |
| _version_ | 1783427263841173504 |
|---|---|
| author | Untch, Michael Thomssen, Christoph Bauerfeind, Ingo Braun, Michael Brucker, Sara Y. Felberbaum, Ricardo Hagemann, Friederike Haidinger, Renate Hönig, Arnd Huober, Jens Jackisch, Christian Kolberg, Hans-Christian Kolberg-Liedtke, Cornelia Kühn, Thorsten Lüftner, Diana Maass, Nicolai Reimer, Toralf Schneeweiss, Andreas Schumacher-Wulf, Eva Schütz, Florian Thill, Marc Wuerstlein, Rachel Fasching, Peter A. Harbeck, Nadia |
| author_facet | Untch, Michael Thomssen, Christoph Bauerfeind, Ingo Braun, Michael Brucker, Sara Y. Felberbaum, Ricardo Hagemann, Friederike Haidinger, Renate Hönig, Arnd Huober, Jens Jackisch, Christian Kolberg, Hans-Christian Kolberg-Liedtke, Cornelia Kühn, Thorsten Lüftner, Diana Maass, Nicolai Reimer, Toralf Schneeweiss, Andreas Schumacher-Wulf, Eva Schütz, Florian Thill, Marc Wuerstlein, Rachel Fasching, Peter A. Harbeck, Nadia |
| author_sort | Untch, Michael |
| collection | PubMed |
| description | The results of the international St. Gallen Consensus Conference for the treatment of patients with primary breast cancer were discussed this year by a working group of leading breast cancer experts in view of the therapy recommendations for everyday clinical practice in Germany. Three of the breast cancer experts are also members of this yearʼs St. Gallen panel. The comparison of the St. Gallen recommendations with the annually updated treatment recommendations of the AGO 2019 as well as the S3 guideline is useful, since the recommendations of the St. Gallen panel represent the opinions of experts from various countries and disciplines. The recommendations of the S3 guideline and AGO are based on evidence-based research of the literature. This yearʼs 16th St. Gallen conference featured the motto “Magnitude of clinical benefit”. In addition to the evidence-based data, each therapeutic decision must also undergo a benefit/risk assessment of the patientʼs individual situation and be discussed with the patient. |
| format | Online Article Text |
| id | pubmed-6570611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65706112019-06-17 Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) Untch, Michael Thomssen, Christoph Bauerfeind, Ingo Braun, Michael Brucker, Sara Y. Felberbaum, Ricardo Hagemann, Friederike Haidinger, Renate Hönig, Arnd Huober, Jens Jackisch, Christian Kolberg, Hans-Christian Kolberg-Liedtke, Cornelia Kühn, Thorsten Lüftner, Diana Maass, Nicolai Reimer, Toralf Schneeweiss, Andreas Schumacher-Wulf, Eva Schütz, Florian Thill, Marc Wuerstlein, Rachel Fasching, Peter A. Harbeck, Nadia Geburtshilfe Frauenheilkd The results of the international St. Gallen Consensus Conference for the treatment of patients with primary breast cancer were discussed this year by a working group of leading breast cancer experts in view of the therapy recommendations for everyday clinical practice in Germany. Three of the breast cancer experts are also members of this yearʼs St. Gallen panel. The comparison of the St. Gallen recommendations with the annually updated treatment recommendations of the AGO 2019 as well as the S3 guideline is useful, since the recommendations of the St. Gallen panel represent the opinions of experts from various countries and disciplines. The recommendations of the S3 guideline and AGO are based on evidence-based research of the literature. This yearʼs 16th St. Gallen conference featured the motto “Magnitude of clinical benefit”. In addition to the evidence-based data, each therapeutic decision must also undergo a benefit/risk assessment of the patientʼs individual situation and be discussed with the patient. Georg Thieme Verlag KG 2019-06 2019-06-14 /pmc/articles/PMC6570611/ /pubmed/31217628 http://dx.doi.org/10.1055/a-0897-6457 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
| spellingShingle | Untch, Michael Thomssen, Christoph Bauerfeind, Ingo Braun, Michael Brucker, Sara Y. Felberbaum, Ricardo Hagemann, Friederike Haidinger, Renate Hönig, Arnd Huober, Jens Jackisch, Christian Kolberg, Hans-Christian Kolberg-Liedtke, Cornelia Kühn, Thorsten Lüftner, Diana Maass, Nicolai Reimer, Toralf Schneeweiss, Andreas Schumacher-Wulf, Eva Schütz, Florian Thill, Marc Wuerstlein, Rachel Fasching, Peter A. Harbeck, Nadia Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) |
| title | Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) |
| title_full | Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) |
| title_fullStr | Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) |
| title_full_unstemmed | Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) |
| title_short | Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019) |
| title_sort | primary therapy of early breast cancer: evidence, controversies, consensus: spectrum of opinion of german specialists on the 16th st. gallen international breast cancer conference (vienna 2019) |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570611/ https://www.ncbi.nlm.nih.gov/pubmed/31217628 http://dx.doi.org/10.1055/a-0897-6457 |
| work_keys_str_mv | AT untchmichael primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT thomssenchristoph primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT bauerfeindingo primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT braunmichael primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT bruckersaray primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT felberbaumricardo primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT hagemannfriederike primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT haidingerrenate primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT honigarnd primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT huoberjens primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT jackischchristian primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT kolberghanschristian primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT kolbergliedtkecornelia primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT kuhnthorsten primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT luftnerdiana primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT maassnicolai primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT reimertoralf primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT schneeweissandreas primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT schumacherwulfeva primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT schutzflorian primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT thillmarc primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT wuerstleinrachel primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT faschingpetera primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 AT harbecknadia primarytherapyofearlybreastcancerevidencecontroversiesconsensusspectrumofopinionofgermanspecialistsonthe16thstgalleninternationalbreastcancerconferencevienna2019 |